Logo
Search
Sign Up
Logo
Oliver Buchannon
Jason Segal

The market makes noise. I tell the story. ASX life sciences companies explained.

The Pulse Check

+1

Catalyst Hunting: The Actinogen Story (ASX: ACW)

Jun 16, 2026

•

10 min read

Catalyst Hunting: The Actinogen Story (ASX: ACW)

Jason Segal
Jason Segal

The Pulse Check

The Hardest Sport in Business: Attention

Jun 15, 2026

•

3 min read

The Hardest Sport in Business: Attention

Jason Segal
Jason Segal

The Pulse Check

+1

A Sweaty Mess: The Botanix Story (ASX: BOT)

Jun 12, 2026

•

8 min read

A Sweaty Mess: The Botanix Story (ASX: BOT)

Jason Segal
Jason Segal

The Pulse Check

The Competitive Landscape of the Healthcare World Cup

Jun 11, 2026

•

6 min read

The Competitive Landscape of the Healthcare World Cup

Jason Segal
Jason Segal

Imricor (ASX: IMR)

+1

Big Game Hunting: The Imricor Story (ASX: IMR)

Jun 10, 2026

•

11 min read

Big Game Hunting: The Imricor Story (ASX: IMR)

Jason Segal
Jason Segal

The Pulse Check

The Big Freeze: Neale’s legacy lives on

Jun 9, 2026

•

4 min read

The Big Freeze: Neale’s legacy lives on

Jason Segal
Jason Segal

The Pulse Check

+1

Opthea Trade Update: The Final Boss Levelled Up

Jun 5, 2026

•

3 min read

Opthea Trade Update: The Final Boss Levelled Up

Jason Segal
Jason Segal

The Pulse Check

 5 Tax Loss Trading Stocks I’m Watching

Jun 4, 2026

•

7 min read

5 Tax Loss Trading Stocks I’m Watching

Jason Segal
Jason Segal

The Pulse Check

+1

Opthea (ASX: OPT) is back: Can you SEE the trade?

Jun 3, 2026

•

2 min read

Opthea (ASX: OPT) is back: Can you SEE the trade?

Jason Segal
Jason Segal

The Pulse Check

+1

Shelf Control: The Cryosite Story (ASX: CTE)

Jun 2, 2026

•

10 min read

Shelf Control: The Cryosite Story (ASX: CTE)

Jason Segal
Jason Segal

The Pulse Check

+1

Two new contracts put Pro Medicus back in focus

Jun 1, 2026

•

4 min read

Two new contracts put Pro Medicus back in focus

Jason Segal
Jason Segal

The Pulse Check

Six months in the chair. Thank you!

May 29, 2026

•

2 min read

Six months in the chair. Thank you!

Jason Segal
Jason Segal

Emyria (ASX: EMD)

+1

Slip Lane to Shroomtown: TGA's Gridlock Unlock

May 28, 2026

•

4 min read

Slip Lane to Shroomtown: TGA's Gridlock Unlock

Jason Segal
Jason Segal

The Pulse Check

+1

Holy Grail Found? The Racura Oncology Story (ASX: RAC)

May 27, 2026

•

8 min read

Holy Grail Found? The Racura Oncology Story (ASX: RAC)

Jason Segal
Jason Segal

The Pulse Check

Investors Beware: The Founder Trap

May 26, 2026

•

8 min read

Investors Beware: The Founder Trap

Jason Segal
Jason Segal

The Pulse Check

+1

Why are Tetratherix (ASX: TTX) shares moving?

May 25, 2026

•

5 min read

Why are Tetratherix (ASX: TTX) shares moving?

Jason Segal
Jason Segal

The Pulse Check

+1

Escaping the Billing Graveyard: The Pacific Edge Story (ASX: PEB)

May 22, 2026

•

9 min read

Escaping the Billing Graveyard: The Pacific Edge Story (ASX: PEB)

Jason Segal
Jason Segal

The Pulse Check

Why Change Management Matters More Than AI in Healthcare

May 21, 2026

•

5 min read

Why Change Management Matters More Than AI in Healthcare

Jason Segal
Jason Segal

The Pulse Check

Vital Signs: Live from Digital Health Festival

May 20, 2026

•

2 min read

Vital Signs: Live from Digital Health Festival

Jason Segal
Jason Segal

The Pulse Check

+1

The Anatomy of a Short Squeeze

May 19, 2026

•

6 min read

The Anatomy of a Short Squeeze

Jason Segal
Jason Segal

The Pulse Check

+1

Bet on the Hare, Get the Tortoise: Clinuvel’s Story (ASX: CUV)

May 18, 2026

•

11 min read

Bet on the Hare, Get the Tortoise: Clinuvel’s Story (ASX: CUV)

Jason Segal
Jason Segal

The Pulse Check

Don’t cook the float

May 15, 2026

•

2 min read

Don’t cook the float

Jason Segal
Jason Segal

The Pulse Check

Innovation Decimation: Budget to Break Biotech

May 14, 2026

•

2 min read

Innovation Decimation: Budget to Break Biotech

Jason Segal
Jason Segal

Acrux (ASX: ACR)

+1

The "Kate Bush" Trade: Acrux's (ASX: ACR) Story

May 13, 2026

•

7 min read

The "Kate Bush" Trade: Acrux's (ASX: ACR) Story

Jason Segal
Jason Segal

The Pulse Check

+1

Not Your Typical Biotech Shed

May 11, 2026

•

4 min read

Not Your Typical Biotech Shed

Jason Segal
Jason Segal
Load more

The Armchair Analyst

Escrow & Trading Policy

© 2026 The Armchair Analyst.
beehiivPowered by beehiiv